These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 8738701

  • 1. Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site.
    Okada T, Sakamoto T, Ishibashi T, Inomata H.
    Graefes Arch Clin Exp Ophthalmol; 1996 Jun; 234(6):359-63. PubMed ID: 8738701
    [Abstract] [Full Text] [Related]

  • 2. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
    Vukojević M, Vukojevic N, Vuković A, Rupčić B, Blažević M, Blažević A.
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
    [Abstract] [Full Text] [Related]

  • 3. Vogt-Koyanagi-Harada syndrome following injury-induced progressive vitiligo.
    Gupta V, Gupta A, Bambery P, Radotra BD, Pandav SS.
    Indian J Ophthalmol; 2001 Mar; 49(1):53-5. PubMed ID: 15887718
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus.
    Inomata H, Sakamoto T.
    Curr Eye Res; 1990 Mar; 9 Suppl():35-40. PubMed ID: 1974489
    [Abstract] [Full Text] [Related]

  • 5. Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease.
    Sakamoto T, Murata T, Inomata H.
    Arch Ophthalmol; 1991 Sep; 109(9):1270-4. PubMed ID: 1929956
    [Abstract] [Full Text] [Related]

  • 6. Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin?
    Prignano F, Betts CM, Lotti T.
    J Electron Microsc (Tokyo); 2008 Jan; 57(1):25-31. PubMed ID: 18174263
    [Abstract] [Full Text] [Related]

  • 7. Inflammatory vitiligo in Vogt-Koyanagi-Harada disease.
    Tsuruta D, Hamada T, Teramae H, Mito H, Ishii M.
    J Am Acad Dermatol; 2001 Jan; 44(1):129-31. PubMed ID: 11148490
    [Abstract] [Full Text] [Related]

  • 8. Histopathologic findings in the alopecia associated with Vogt-Koyanagi-Harada disease.
    DiPreta EA, Smith KJ, Williams J, Skelton AH.
    J Cutan Med Surg; 2000 Jul; 4(3):156-60. PubMed ID: 11003722
    [Abstract] [Full Text] [Related]

  • 9. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
    Norose K, Yano A, Wang XC, Tokushima T, Umihira J, Seki A, Nohara M, Segawa K.
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
    [Abstract] [Full Text] [Related]

  • 10. Vogt-Koyanagi-Harada disease: extensive vitiligo with prodromal generalized erythroderma.
    Wong SS, Ng SK, Lee HM.
    Dermatology; 1999 Jan; 198(1):65-8. PubMed ID: 10026405
    [Abstract] [Full Text] [Related]

  • 11. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M.
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [Abstract] [Full Text] [Related]

  • 12. [Vitiligo revealing Vogt -Koyanagi-Harada disease].
    Amraoui ME, Zemmez Y, Bouhamidi A, Frikh R, Hjira N, Boui M.
    Pan Afr Med J; 2017 Mar; 27():220. PubMed ID: 28979622
    [Abstract] [Full Text] [Related]

  • 13. Successful Treatment of Vitiligo Associated with Vogt-Koyanagi-Harada Disease.
    Bayer ML, Chiu YE.
    Pediatr Dermatol; 2017 Mar; 34(2):204-205. PubMed ID: 27981622
    [Abstract] [Full Text] [Related]

  • 14. Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders.
    Egbeto IA, Garelli CJ, Piedra-Mora C, Wong NB, David CN, Robinson NA, Richmond JM.
    Front Immunol; 2020 Mar; 11():590558. PubMed ID: 33384688
    [Abstract] [Full Text] [Related]

  • 15. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
    Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, Sugamoto Y, Futagami Y, Itoh K, Mochizuki M.
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469
    [Abstract] [Full Text] [Related]

  • 16. Conjunctival nodules associated with Vogt-Koyanagi-Harada disease.
    Nakao K, Shimonagano Y, Doi N, Sakamoto T.
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1383-6. PubMed ID: 17701198
    [Abstract] [Full Text] [Related]

  • 17. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.
    Abad S, Wieërs G, Colau D, Wildmann C, Delair E, Dhote R, Brézin AP, Kawakami Y, Coulie PG, van der Bruggen P.
    Mol Vis; 2014 Sep; 20():956-69. PubMed ID: 24991188
    [Abstract] [Full Text] [Related]

  • 18. Immunopathologic study of Vogt-Koyanagi-Harada syndrome.
    Chan CC, Palestine AG, Kuwabara T, Nussenblatt RB.
    Am J Ophthalmol; 1988 Jun 15; 105(6):607-11. PubMed ID: 3259837
    [Abstract] [Full Text] [Related]

  • 19. Peripheral T-cell activation in non-segmental vitiligo.
    Mahmoud F, Abul H, al-Saleh Q, Haines D, Burleson J, Morgan G.
    J Dermatol; 1998 Oct 15; 25(10):637-40. PubMed ID: 9830261
    [Abstract] [Full Text] [Related]

  • 20. Immunocytologic findings in a case of Vogt-Koyanagi-Harada syndrome.
    Kahn M, Pepose JS, Green WR, Miller J, Foos RY.
    Ophthalmology; 1993 Aug 15; 100(8):1191-8. PubMed ID: 8341501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.